318 related articles for article (PubMed ID: 10652192)
41. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation.
Fukuda D; Enomoto S; Nagai R; Sata M
Biomed Pharmacother; 2009 Dec; 63(10):754-61. PubMed ID: 19304450
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin-converting enzyme inhibition augments coronary release of tissue plasminogen activator in women but not in men.
Matsumoto T; Takashima H; Nakae I; Yamane T; Hayashi H; Horie M;
Hypertension; 2010 Sep; 56(3):364-8. PubMed ID: 20606106
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
[TBL] [Abstract][Full Text] [Related]
45. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats.
Usui M; Egashira K; Kitamoto S; Koyanagi M; Katoh M; Kataoka C; Shimokawa H; Takeshita A
Hypertension; 1999 Oct; 34(4 Pt 1):546-51. PubMed ID: 10523324
[TBL] [Abstract][Full Text] [Related]
46. Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue.
Ekström M; Liska J; Eriksson P; Sverremark-Ekström E; Tornvall P
Thromb Haemost; 2012 Sep; 108(3):485-92. PubMed ID: 22740034
[TBL] [Abstract][Full Text] [Related]
47. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
Brown NJ; Muldowney JA; Vaughan DE
Hypertension; 2006 Mar; 47(3):441-8. PubMed ID: 16432054
[TBL] [Abstract][Full Text] [Related]
48. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
Chen R; Iwai M; Wu L; Suzuki J; Min LJ; Shiuchi T; Sugaya T; Liu HW; Cui TX; Horiuchi M
Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679
[TBL] [Abstract][Full Text] [Related]
49. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
[TBL] [Abstract][Full Text] [Related]
50. Modulation of angiotensin-converting enzyme by nitric oxide.
Ackermann A; Fernández-Alfonso MS; Sánchez de Rojas R; Ortega T; Paul M; González C
Br J Pharmacol; 1998 May; 124(2):291-8. PubMed ID: 9641545
[TBL] [Abstract][Full Text] [Related]
51. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
[TBL] [Abstract][Full Text] [Related]
52. Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension.
Sharma DK; Manral A; Saini V; Singh A; Srinivasan BP; Tiwari M
Eur J Pharmacol; 2012 Sep; 691(1-3):198-208. PubMed ID: 22819707
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta.
Hamdan AD; Quist WC; Gagne JB; Feener EP
Circulation; 1996 Mar; 93(6):1073-8. PubMed ID: 8653825
[TBL] [Abstract][Full Text] [Related]
54. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
Akuzawa N; Nakamura T; Kurashina T; Saito Y; Hoshino J; Sakamoto H; Sumino H; Ono Z; Nagai R
Am J Hypertens; 1998 Jun; 11(6 Pt 1):697-707. PubMed ID: 9657629
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
Kitakaze M; Node K; Minamino T; Asanuma H; Ueda Y; Kosaka H; Kuzuya T; Hori M
J Mol Cell Cardiol; 1998 Nov; 30(11):2461-6. PubMed ID: 9925380
[TBL] [Abstract][Full Text] [Related]
56. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Li P; Kondo T; Numaguchi Y; Kobayashi K; Aoki M; Inoue N; Okumura K; Murohara T
Hypertension; 2008 Feb; 51(2):252-8. PubMed ID: 18086946
[TBL] [Abstract][Full Text] [Related]
57. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
58. Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats.
Shimizu H; Nakagami H; Osako MK; Nakagami F; Kunugiza Y; Tomita T; Yoshikawa H; Rakugi H; Ogihara T; Morishita R
Hypertens Res; 2009 Sep; 32(9):786-90. PubMed ID: 19590507
[TBL] [Abstract][Full Text] [Related]
59. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
Pechánová O; Bernátová I; Pelouch V; Simko F
J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842
[TBL] [Abstract][Full Text] [Related]
60. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
Kobayashi N; Hara K; Higashi T; Matsuoka H
Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
